ECM
LLY icon

Estabrook Capital Management’s Eli Lilly LLY Stock Holding History

Estabrook Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.5M Buy
3,808
+6
+0.2% +$6.08K 0.51% 48
2025
Q4 		$4.09M Sell
3,802
-260
-6% -$249K 0.6% 40
2025
Q3 		$3.1M Sell
4,062
-25
-0.6% -$18.6K 0.45% 54
2025
Q2 		$3.19M Sell
4,087
-600
-13% -$466K 0.49% 49
2025
Q1 		$3.87M Sell
4,687
-1,165
-20% -$969K 0.63% 42
2024
Q4 		$4.52M Sell
5,852
-242
-4% -$200K 0.7% 39
2024
Q3 		$5.4M Sell
6,094
-600
-9% -$539K 0.81% 35
2024
Q2 		$6.06M Sell
6,694
-434
-6% -$347K 0.93% 31
2024
Q1 		$5.55M Sell
7,128
-538
-7% -$383K 0.86% 34
2023
Q4 		$4.47M Sell
7,666
-470
-6% -$274K 0.73% 38
2023
Q3 		$4.37M Sell
8,136
-749
-8% -$386K 0.77% 38
2023
Q2 		$4.17M Sell
8,885
-805
-8% -$338K 0.69% 39
2023
Q1 		$3.33M Buy
9,690
+100
+1% +$33.7K 0.58% 50
2022
Q4 		$3.51M Sell
9,590
-340
-3% -$121K 0.6% 47
2022
Q3 		$3.21M Sell
9,930
-425
-4% -$135K 0.6% 46
2022
Q2 		$3.36M Sell
10,355
-151
-1% -$45.3K 0.58% 48
2022
Q1 		$3.01M Sell
10,506
-675
-6% -$174K 0.44% 61
2021
Q4 		$3.09M Sell
11,181
-1,959
-15% -$497K 0.44% 60
2021
Q3 		$3.04M Sell
13,140
-360
-3% -$88.9K 0.48% 59
2021
Q2 		$3.1M Sell
13,500
-170
-1% -$34.1K 0.47% 60
2021
Q1 		$2.55M Sell
13,670
-300
-2% -$58.7K 0.39% 62
2020
Q4 		$2.36M Sell
13,970
-182
-1% -$27.2K 0.39% 62
2020
Q3 		$2.09M Sell
14,152
-603
-4% -$93.3K 0.38% 61
2020
Q2 		$2.42M Sell
14,755
-100
-0.7% -$15.3K 0.46% 55
2020
Q1 		$2.06M Sell
14,855
-50
-0.3% -$6.87K 0.43% 55
2019
Q4 		$1.96M Sell
14,905
-100
-0.7% -$11.6K 0.29% 64
2019
Q3 		$1.68M Buy
15,005
+110
+0.7% +$12.2K 0.28% 63
2019
Q2 		$1.65M Sell
14,895
-100
-0.7% -$11.8K 0.27% 63
2019
Q1 		$1.95M Sell
14,995
-274
-2% -$33.3K 0.32% 60
2018
Q4 		$1.77M Sell
15,269
-479
-3% -$53.5K 0.33% 57
2018
Q3 		$1.69M Sell
15,748
-175
-1% -$17.5K 0.26% 64
2018
Q2 		$1.36M Sell
15,923
-450
-3% -$37K 0.21% 71
2018
Q1 		$1.27M Sell
16,373
-302
-2% -$24.3K 0.2% 74
2017
Q4 		$1.41M Hold
16,675
– – 0.21% 70
2017
Q3 		$1.43M Hold
16,675
– – 0.22% 71
2017
Q2 		$1.37M Hold
16,675
– – 0.22% 73
2017
Q1 		$1.4M Sell
16,675
-7,500
-31% -$601K 0.22% 70
2016
Q4 		$1.78M Hold
24,175
– – 0.28% 67
2016
Q3 		$1.94M Sell
24,175
-100
-0.4% -$8K 0.29% 64
2016
Q2 		$1.91M Hold
24,275
– – 0.29% 64
2016
Q1 		$1.75M Sell
24,275
-300
-1% -$22.7K 0.26% 62
2015
Q4 		$2.07M Sell
24,575
-600
-2% -$49.8K 0.3% 60
2015
Q3 		$2.11M Sell
25,175
-100
-0.4% -$8.44K 0.3% 60
2015
Q2 		$2.11M Sell
25,275
-285
-1% -$21.7K 0.26% 62
2015
Q1 		$1.86M Sell
25,560
-2,750
-10% -$196K 0.22% 66
2014
Q4 		$1.95M Sell
28,310
-100
-0.4% -$6.75K 0.22% 62
2014
Q3 		$1.84M Sell
28,410
-135
-0.5% -$8.55K 0.2% 63
2014
Q2 		$1.77M Hold
28,545
– – 0.18% 70
2014
Q1 		$1.68M Sell
28,545
-5,100
-15% -$285K 0.17% 74
2013
Q4 		$1.72M Buy
33,645
+5,550
+20% +$278K 0.18% 73
2013
Q3 		$1.41M Sell
28,095
-2,750
-9% -$144K 0.15% 82
2013
Q2 		$1.52M Buy
+30,845
New +$1.68M 0.16% 82

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Estabrook Capital Management's LLY Position: Q1 2026 in Review

Estabrook Capital Management increased its Eli Lilly (LLY) stake by 0.16% in Q1 2026, buying an estimated $6.08K and bringing the position to 3,808 shares worth $3.5M. The position accounts for 0.51% of the portfolio, ranked #48.

Estabrook Capital Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.06M in Q2 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Estabrook Capital Management held 3,808 shares of Eli Lilly worth $3.5M as of Q1 2026.
  • Estabrook Capital Management bought 6 Eli Lilly shares in Q1 2026, an estimated $6.08K.
  • Eli Lilly made up 0.51% of Estabrook Capital Management's portfolio in Q1 2026, its #48 holding.
  • Estabrook Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Estabrook Capital Management's Eli Lilly position peaked at $6.06M in Q2 2024.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Estabrook Capital Management's 13F filing for Q1 2026, filed 14 May 2026.